Unknown

Dataset Information

0

Conjugation of Transforming Growth Factor Beta to Antigen-Loaded Poly(lactide- co-glycolide) Nanoparticles Enhances Efficiency of Antigen-Specific Tolerance.


ABSTRACT: Current strategies for treating autoimmunity involve the administration of broad-acting immunosuppressive agents that impair healthy immunity. Intravenous (i.v.) administration of poly(lactide- co-glycolide) nanoparticles (NPs) containing disease-relevant antigens (Ag-NPs) have demonstrated antigen (Ag)-specific immune tolerance in models of autoimmunity. However, subcutaneous (s.c.) delivery of Ag-NPs has not been effective. This investigation tested the hypothesis that codelivery of the immunomodulatory cytokine, transforming growth factor beta 1 (TGF-?), on Ag-NPs would modulate the immune response to Ag-NPs and improve the efficiency of tolerance induction. TGF-? was coupled to the surface of Ag-NPs such that the loadings of Ag and TGF-? were independently tunable. The particles demonstrated bioactive delivery of Ag and TGF-? in vitro by reducing the inflammatory phenotype of bone marrow-derived dendritic cells and inducing regulatory T cells in a coculture system. Using an in vivo mouse model for multiple sclerosis, experimental autoimmune encephalomyelitis, TGF-? codelivery on Ag-NPs resulted in improved efficacy at lower doses by i.v. administration and significantly reduced disease severity by s.c. administration. This study demonstrates that the codelivery of immunomodulatory cytokines on Ag-NPs may enhance the efficacy of Ag-specific tolerance therapies by programming Ag presenting cells for more efficient tolerance induction.

SUBMITTER: Casey LM 

PROVIDER: S-EPMC6850215 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Conjugation of Transforming Growth Factor Beta to Antigen-Loaded Poly(lactide- co-glycolide) Nanoparticles Enhances Efficiency of Antigen-Specific Tolerance.

Casey Liam M LM   Pearson Ryan M RM   Hughes Kevin R KR   Liu Jeffrey M H JMH   Rose Justin A JA   North Madeleine G MG   Wang Leon Z LZ   Lei Mei M   Miller Stephen D SD   Shea Lonnie D LD  

Bioconjugate chemistry 20171130 3


Current strategies for treating autoimmunity involve the administration of broad-acting immunosuppressive agents that impair healthy immunity. Intravenous (i.v.) administration of poly(lactide- co-glycolide) nanoparticles (NPs) containing disease-relevant antigens (Ag-NPs) have demonstrated antigen (Ag)-specific immune tolerance in models of autoimmunity. However, subcutaneous (s.c.) delivery of Ag-NPs has not been effective. This investigation tested the hypothesis that codelivery of the immuno  ...[more]

Similar Datasets

| S-EPMC3552518 | biostudies-literature
| S-EPMC4681614 | biostudies-literature
| S-EPMC11007221 | biostudies-literature
| S-EPMC3041252 | biostudies-other
| S-EPMC4954769 | biostudies-literature
| S-EPMC7750808 | biostudies-literature
| S-EPMC4215912 | biostudies-literature
| S-EPMC6333394 | biostudies-literature
| S-EPMC7026499 | biostudies-literature
| S-EPMC5096963 | biostudies-literature